NCT06835959 Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
| NCT ID | NCT06835959 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | Hypertension in Pregnancy |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-16 |
| Primary Completion | 2027-07-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-05-16 with a primary completion date of 2027-07-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.
Eligibility Criteria
Inclusion Criteria: * Age 18-50 * English or Spanish speaking * A diagnosis of gestational (20-26 weeks gestational age) or chronic hypertension (8-26 weeks gestational age) * Singleton or multiple gestation pregnancy, * A patient of the University of Massachusetts Memorial Health Obstetrics/Maternal and Fetal Medicine clinics in Worcester, Massachusetts * Willing to share home blood pressure monitoring data * Comfortable with the use of smartphones and mobile apps Exclusion Criteria: * Severe hypertension (Systolic blood pressure ≥160 mmHg or Diastolic blood pressure ≥100 mmHg) * Current diagnosis of preeclampsia * Active substance use * Serious physical illness (e.g., unable to interact with a smart device) * Enrolled in another home blood pressure monitoring program * Excluded from study participation by their provider * Inability to provide informed consent * Prisoners/institutionalized individuals
Contact & Investigator
Lara Kovell, MD,MSc
PRINCIPAL INVESTIGATOR
University of Massachusetts Medical School, Worcester
Frequently Asked Questions
Who can join the NCT06835959 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Hypertension in Pregnancy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06835959 currently recruiting?
Yes, NCT06835959 is actively recruiting participants. Contact the research team at lara.kovell2@umassmed.edu for enrollment information.
Where is the NCT06835959 trial being conducted?
This trial is being conducted at Worcester, United States.
Who is sponsoring the NCT06835959 clinical trial?
NCT06835959 is sponsored by University of Massachusetts, Worcester. The principal investigator is Lara Kovell, MD,MSc at University of Massachusetts Medical School, Worcester. The trial plans to enroll 100 participants.